FDA Panel Recommends RSV Shot to Protect Infantsnews2023-06-08T20:11:09+00:00June 8th, 2023|The New York Times|
FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Oldernews2023-05-31T22:35:58+00:00May 31st, 2023|The New York Times|
Why The F.D.A. Should Move Birth Control Over the Counternews2023-05-22T14:28:45+00:00May 22nd, 2023|The New York Times|
Drug Shortages Near an All-Time High, Leading to Rationingnews2023-05-17T13:31:02+00:00May 17th, 2023|The New York Times|
Esto se sabe sobre Opill, la nueva ‘minipíldora’ anticonceptivanews2023-05-13T09:00:31+00:00May 13th, 2023|The New York Times|
FDA Approves New Drug to Treat Hot Flashesnews2023-05-12T20:09:58+00:00May 12th, 2023|The New York Times|
What an Over-the-Counter Birth Control Pill Could Mean for Younews2023-05-10T19:54:43+00:00May 10th, 2023|The New York Times|
F.D.A. Advisers Say Benefits of Over-the-Counter Birth Control Pill Outweigh Risksnews2023-05-10T17:21:21+00:00May 10th, 2023|The New York Times|
F.D.A. Advisers Weigh Allowing First U.S. Over-the-Counter Birth Control Pillnews2023-05-10T12:33:32+00:00May 10th, 2023|The New York Times|
